We can't find the internet
Attempting to reconnect
17072.1 PFLS-LS
17072.1 PFLS-LS
Résumé
Drugs Activated When Needed (DAWN)
Textes supplémentaires
Abstract
The use of delivery vehicles is at the basis of better tolerable and more efficacious novel classes of targeted drugs [termed Antibody- (ADC-)or Small molecule-(SMDC-)Drug Conjugates). Until now the development of ADC and SMDC relies on target cells internalization, which is difficult to measure and exploit. Here we will develop a novel and superior class of ADC and SMDC which will not require internalization of delivery vehicles and will liberate the toxic payload on demand.
Participants
Martin Mattarella
Wirtschaftspartner
(martin.mattarella@philochem.ch
Philochem AG CHE-113.181.443 Martin Mattarella Libernstrasse 3 8112 Otelfingen ZH CH
Dario Neri
Kontaktperson
dario.neri@pharma.ethz.ch
ETH Zürich Inst. of Pharmac. Sciences Dario Neri HCI G496 / Wolfgang-Pauli-Strasse 10 8093 Zürich ZH CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2014-12-31
- Date de fin
- 2017-12-31
- Coûts totaux approuvés
- CHF 166021.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%